Variant report
Variant | nsv916705 |
---|---|
Chromosome Location | chr13:92549110-92575114 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529707905 | chr13:92549196-92549197 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs375239440 | chr13:92549210-92549211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369524063 | chr13:92549230-92549231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139144986 | chr13:92549281-92549282 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs66826503 | chr13:92549282-92549283 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs61559455 | chr13:92549283-92549284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs71904228 | chr13:92549290-92549291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs397766659 | chr13:92549292-92549293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185501256 | chr13:92549293-92549294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190438476 | chr13:92549301-92549302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559540554 | chr13:92549305-92549306 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528705774 | chr13:92549315-92549316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375127194 | chr13:92549388-92549389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs9301758 | chr13:92549424-92549425 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs180866656 | chr13:92549454-92549455 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs74106571 | chr13:92549463-92549464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184545428 | chr13:92549501-92549502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs34783532 | chr13:92549589-92549590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs71113773 | chr13:92549622-92549623 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139498133 | chr13:92549623-92549624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569656273 | chr13:92549625-92549626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs398023942 | chr13:92549626-92549627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs535064819 | chr13:92549631-92549632 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549086389 | chr13:92549642-92549643 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565607509 | chr13:92549685-92549686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188467529 | chr13:92549726-92549727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181300618 | chr13:92549734-92549735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557510585 | chr13:92549742-92549743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577563058 | chr13:92549758-92549759 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9589367 | chr13:92549765-92549766 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs185523635 | chr13:92549799-92549800 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138881923 | chr13:92549852-92549853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs542628047 | chr13:92549934-92549935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375227995 | chr13:92550041-92550042 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs78008812 | chr13:92550057-92550058 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs190376302 | chr13:92550083-92550084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs111567261 | chr13:92550097-92550098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545644048 | chr13:92550111-92550112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148987229 | chr13:92550129-92550130 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs531270101 | chr13:92550143-92550144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551302247 | chr13:92550162-92550163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143062557 | chr13:92550175-92550176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs116182850 | chr13:92550177-92550178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548688600 | chr13:92550223-92550224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs76060360 | chr13:92550230-92550231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9583968 | chr13:92550263-92550264 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs117281330 | chr13:92550318-92550319 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs115147296 | chr13:92550329-92550330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs372715179 | chr13:92550364-92550365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568374793 | chr13:92550393-92550394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:92543600-92550400 | Weak transcription | Primary hematopoietic stem cells | blood |
2 | chr13:92548600-92550000 | Enhancers | HUVEC | blood vessel |
3 | chr13:92550000-92552200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr13:92550400-92551000 | Enhancers | Primary hematopoietic stem cells | blood |
5 | chr13:92550800-92551800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr13:92555600-92557400 | Enhancers | HUVEC | blood vessel |
7 | chr13:92556200-92557200 | Enhancers | GM12878-XiMat | blood |
8 | chr13:92557400-92558400 | Weak transcription | HUVEC | blood vessel |
9 | chr13:92558200-92558600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr13:92558400-92559000 | Enhancers | HUVEC | blood vessel |
11 | chr13:92559000-92559600 | Weak transcription | HUVEC | blood vessel |
12 | chr13:92559600-92560000 | Enhancers | HUVEC | blood vessel |
13 | chr13:92560000-92560600 | Flanking Active TSS | HUVEC | blood vessel |
14 | chr13:92560600-92561400 | Active TSS | HUVEC | blood vessel |
15 | chr13:92565600-92566200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr13:92571800-92572200 | Enhancers | Fetal Heart | heart |